Polaryx Therapeutics

IPO

Combating Lysosomal Storage Disorders

Public · Paramus, United States · Founded 2014 · $10.0M raised

Employees
1–10
Founded
2014
Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M Corporate RoundMay 2026
Rounds
1
Type
Public

About

Polaryx Therapeutics is a clinical-stage biotechnology company developing novel therapies for Batten disease and other neuronal ceroid lipofuscinoses (NCLs), a group of devastating inherited neurodegenerative disorders. The company's lead program focuses on restoring lysosomal function through small molecule approaches to slow or halt disease progression.

Summary

Polaryx Therapeutics is a Biotech company based in Paramus, United States, founded in 2014. It has raised $10.0M in total across 1 round, most recently a $10.0M Corporate Round round in May 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMay 2026
$10.0M

Sign up to see all 2 rounds

Direct Listing through Corporate Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Polaryx Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/polaryx-therapeutics"><img src="https://indexed.vc/api/badge/company/polaryx-therapeutics" alt="Polaryx Therapeutics on Indexed.vc" width="260" height="76" /></a>